{"title":"An Analysis on the Effect of the Government R&D Subsidies on the Private R&D Investments : in the Case of the Pharmaceutical Industry","authors":"Jin Sakong, You-Ho Shin","doi":"10.4332/KJHPA.2010.20.1.183","DOIUrl":null,"url":null,"abstract":"The purpose of this study is to analyze the effect of the R&D subsidies by the government on the private firms` R&D investments in the Korean pharmaceutical industry, which are supposed to have positive effects on their economic performance. We also estimate the relationship between the private firms` R&D investments and firms` economic outcome. Empirical analysis is done by Error Component 2 Stage Least Squares(EC2SLS) estimation using 43 pharmaceutical firms` 8 years` panel data. The elasticity of the government R&D subsidies on the private R&D investments is 0.021%, which we cannot say `efficient`. Also R&D investments have positive effects on the economic outcome of the pharmaceutical firms, as we expected. We propose several suggestions in the conclusion for the efficient way of government R&D subsidies to induce more private R&D investments.","PeriodicalId":253456,"journal":{"name":"Korean Journal of Health Policy and Administration","volume":"7 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2010-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Journal of Health Policy and Administration","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4332/KJHPA.2010.20.1.183","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
The purpose of this study is to analyze the effect of the R&D subsidies by the government on the private firms` R&D investments in the Korean pharmaceutical industry, which are supposed to have positive effects on their economic performance. We also estimate the relationship between the private firms` R&D investments and firms` economic outcome. Empirical analysis is done by Error Component 2 Stage Least Squares(EC2SLS) estimation using 43 pharmaceutical firms` 8 years` panel data. The elasticity of the government R&D subsidies on the private R&D investments is 0.021%, which we cannot say `efficient`. Also R&D investments have positive effects on the economic outcome of the pharmaceutical firms, as we expected. We propose several suggestions in the conclusion for the efficient way of government R&D subsidies to induce more private R&D investments.